MIRN Insider Trading Activity and SEC Form 4 Filings
MIRN insider trading summary
No open-market insider purchases or sales of Mirna Therapeutics, Inc. (MIRN) have been reported on SEC Form 4 in the past 12 months.
Latest MIRN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 1, 2016 | Jon Irvin | Vice President, Finance | Sell | $402 (280 @ $1.43) |
| Nov 11, 2016 | Jon Irvin | Vice President, Finance | Sell | $218 (150 @ $1.45) |
| Nov 1, 2016 | Jon Irvin | Vice President, Finance | Sell | $359 (280 @ $1.28) |
| Oct 3, 2016 | Jon Irvin | Vice President, Finance | Sell | $481 (250 @ $1.93) |
| Oct 6, 2015 | Krishna Kittu Kolluri | 10% Owner | Buy | $6.0M (857,142 @ $7.00) |
| Oct 6, 2015 | Harry R Weller | 10% Owner | Buy | $6.0M (857,142 @ $7.00) |
| Oct 6, 2015 | M James Barrett | 10% Owner | Buy | $6.0M (857,142 @ $7.00) |
| Oct 6, 2015 | Srinivas Akkaraju | 10% Owner | Buy | $6.0M (857,142 @ $7.00) |
| Oct 6, 2015 | David M Mott | 10% Owner | Buy | $6.0M (857,142 @ $7.00) |
| Oct 6, 2015 | James Healy | 10% Owner | Buy | $6.0M (857,142 @ $7.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.